FDA approves drug to reduce triglycerides in adults with familial chylomicronemia syndrome

U.S. Food and Drug Administration (FDAU.S. Food and Drug Administration (FDA) approved Redemplo (plozasiran) as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS).) approved Redemplo (plozasiran) as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS).